<DOC>
	<DOC>NCT00094627</DOC>
	<brief_summary>The purpose of the study is to test the safety and effectiveness of the Investigational Drug on insomnia.</brief_summary>
	<brief_title>Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Gaboxadol</mesh_term>
	<criteria>Adult patients with a diagnosis of primary insomnia and in good physical and mental health Adult patients with other medical , neurological and sleep disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>